Pending — not yet graded
“Axis Securities forecasts an upside potential of 12.2% for Healthcare Global Enterprises, with a target price of Rs 820. The company is positioned as a leading pure-play oncology company in India, with a network of nearly 22 Comprehensive Cancer Centers.”
Axis Securities Analysis’s track record: 3 graded calls · 95% CI 21–94%
Healthcare Global EnterprisesBullishCalled 03 Sep 2026
This call hasn't reached its evaluation window yet — the HIT/MISS verdict will appear here once it's graded against real price data. Save it above to find it again from your profile.
Read the original articleSee Axis Securities Analysis’s full track record